Search Results
Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark
Department of Clinical Epidemiology, Aarhus University Hospital and Aarhus University, Aarhus, Denmark
Search for other papers by Sigrid Bjerge Gribsholt in
Google Scholar
PubMed
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Morten Schmidt in
Google Scholar
PubMed
Search for other papers by Eskild Bendix Kristiansen in
Google Scholar
PubMed
Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
Search for other papers by Bjørn Richelsen in
Google Scholar
PubMed
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
Search for other papers by Henrik Toft Sørensen in
Google Scholar
PubMed
-0452 . Declaration of interest SBG has received speaking fees from Novo Nordisk A/S. All other authors declare they have no conflicts of interest. Funding This research was supported by Department of Clinical Epidemiology at Aarhus University Hospital, the
Search for other papers by Yanmei Lou in
Google Scholar
PubMed
Search for other papers by Yanyan Zhang in
Google Scholar
PubMed
Search for other papers by Ping Zhao in
Google Scholar
PubMed
Search for other papers by Pei Qin in
Google Scholar
PubMed
Search for other papers by Changyi Wang in
Google Scholar
PubMed
Search for other papers by Jianping Ma in
Google Scholar
PubMed
Search for other papers by Xiaolin Peng in
Google Scholar
PubMed
Search for other papers by Hongen Chen in
Google Scholar
PubMed
Search for other papers by Dan Zhao in
Google Scholar
PubMed
Search for other papers by Shan Xu in
Google Scholar
PubMed
Search for other papers by Li Wang in
Google Scholar
PubMed
Search for other papers by Ming Zhang in
Google Scholar
PubMed
Search for other papers by Dongsheng Hu in
Google Scholar
PubMed
Search for other papers by Fulan Hu in
Google Scholar
PubMed
regression dilution in long-term follow-up of prospective studies . American Journal of Epidemiology 1999 150 341 – 353 . ( https://doi.org/10.1093/oxfordjournals.aje.a010013 ) 19 Geva M Shlomai G Berkovich A Maor E Leibowitz A Tenenbaum A
Search for other papers by Yunyi Ding in
Google Scholar
PubMed
Search for other papers by Siyao Lv in
Google Scholar
PubMed
Search for other papers by Ruijie Xie in
Google Scholar
PubMed
Search for other papers by Wei Ye in
Google Scholar
PubMed
Search for other papers by Yichen Luo in
Google Scholar
PubMed
Search for other papers by Yayu Li in
Google Scholar
PubMed
levels equal to or surpassing 6.5%, or the administration of pharmacological agents for diabetes management. The eGFR was ascertained by employing the Chronic Kidney Disease Epidemiology Collaboration algorithm ( 30 ). DKD is defined as diabetes with the
Search for other papers by Clemens Kamrath in
Google Scholar
PubMed
Institute of Epidemiology and Medical Biometry, ZIBMT, Ulm University, Ulm, Germany
Search for other papers by Alexander Eckert in
Google Scholar
PubMed
Search for other papers by Birgit Rami-Merhar in
Google Scholar
PubMed
Search for other papers by Sebastian Kummer in
Google Scholar
PubMed
Search for other papers by Martin Wabitsch in
Google Scholar
PubMed
Search for other papers by Katharina Laubner in
Google Scholar
PubMed
Search for other papers by Florian Kopp in
Google Scholar
PubMed
Search for other papers by Silvia Müther in
Google Scholar
PubMed
Search for other papers by Steffen Mühldorfer in
Google Scholar
PubMed
Institute of Epidemiology and Medical Biometry, ZIBMT, Ulm University, Ulm, Germany
Search for other papers by Reinhard W Holl in
Google Scholar
PubMed
software (clinical data managers, Institute of Epidemiology and Medical Biometry (ZIBMT), Ulm University, Ulm, Germany). The authors wish to thank all centers contributing to this analysis: Augsburg IV. Med. Uni-Klinik, Bad Mergentheim
German Center for Diabetes Research (DZD), Neuherberg, Germany
Search for other papers by Marie Auzanneau in
Google Scholar
PubMed
German Center for Diabetes Research (DZD), Neuherberg, Germany
Search for other papers by Alexander J Eckert in
Google Scholar
PubMed
Department of Internal Medicine IV, University Hospital Tübingen, Germany
Institute of Diabetes Research and Metabolic Diseases (IDM) of the Helmholtz Center Munich at the University of Tübingen, Tübingen, Germany
Search for other papers by Andreas Fritsche in
Google Scholar
PubMed
Division of Endocrinology and Diabetology, Department of Internal Medicine 1, University Hospital Ulm, Ulm, Germany
Institute for Clinical Chemistry and Pathobiochemistry, Department for Diagnostic Laboratory Medicine, University Hospital Tübingen, Tübingen, Germany
Search for other papers by Martin Heni in
Google Scholar
PubMed
Institute of Health Services Research and Health Economics, Center for Health and Society, Faculty of Medicine, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
Institute of Health Services Research and Health Economics, German Diabetes Center (DDZ), Leibniz Centre for Diabetes Research at Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany
Search for other papers by Andrea Icks in
Google Scholar
PubMed
Department of Psychiatry and Psychotherapy II, University Hospital Ulm, Um, Germany
Search for other papers by Annabel S Mueller-Stierlin in
Google Scholar
PubMed
Search for other papers by Ana Dugic in
Google Scholar
PubMed
Search for other papers by Alexander Risse in
Google Scholar
PubMed
German Center for Diabetes Research (DZD), Neuherberg, Germany
Search for other papers by Stefanie Lanzinger in
Google Scholar
PubMed
German Center for Diabetes Research (DZD), Neuherberg, Germany
Search for other papers by Reinhard W Holl in
Google Scholar
PubMed
, Institute of Epidemiology and Medical Biometry, University of Ulm) and Mrs J. Loske (Research Data Center of the German Federal Statistical Office, Destatis). References 1 Sun H Saeedi P Karuranga S Pinkepank M Ogurtsova K Duncan BB
Search for other papers by Chengnan Guo in
Google Scholar
PubMed
Search for other papers by Yixi Xu in
Google Scholar
PubMed
Search for other papers by Yange Ma in
Google Scholar
PubMed
Search for other papers by Xin Xu in
Google Scholar
PubMed
Search for other papers by Fang Peng in
Google Scholar
PubMed
Search for other papers by Hui-hui Li in
Google Scholar
PubMed
Search for other papers by Dongzhen Jin in
Google Scholar
PubMed
Search for other papers by Shu-zhen Zhao in
Google Scholar
PubMed
Search for other papers by Zhezheng Xia in
Google Scholar
PubMed
Search for other papers by Mengyuan Lai in
Google Scholar
PubMed
Search for other papers by Mingzhu Che in
Google Scholar
PubMed
Search for other papers by Ruogu Huang in
Google Scholar
PubMed
Search for other papers by Yanan Wang in
Google Scholar
PubMed
Search for other papers by Depeng Jiang in
Google Scholar
PubMed
Search for other papers by Chao Zheng in
Google Scholar
PubMed
Eye Hospital and School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, Zhejiang, China
National Clinical Research Center for Ocular Diseases, Wenzhou, Zhejiang, China
Search for other papers by Guangyun Mao in
Google Scholar
PubMed
Although previous studies demonstrate that trehalose can help maintain glucose homeostasis in healthy humans, its role and joint effect with glutamate on diabetic retinopathy (DR) remain unclear. We aimed to comprehensively quantify the associations of trehalose and glutamate with DR. This study included 69 pairs of DR and matched type 2 diabetic (T2D) patients. Serum trehalose and glutamate were determined via ultra-performance liquid chromatography-electrospray ionization-tandem mass spectrometry system. Covariates were collected by a standardized questionnaire, clinical examinations and laboratory assessments. Individual and joint association of trehalose and glutamate with DR were quantified by multiple conditional logistic regression models. The adjusted odds of DR averagely decreased by 86% (odds ratio (OR): 0.14; 95% CI: 0.06, 0.33) with per interquartile range increase of trehalose. Comparing with the lowest quartile, adjusted OR (95% CI) were 0.20 (0.05, 0.83), 0.14 (0.03, 0.63) and 0.01 (<0.01, 0.05) for participants in the second, third and fourth quartiles of trehalose, respectively. In addition, as compared to their counterparts, T2D patients with lower trehalose (<median) and higher glutamate (≥median) had the highest odds of DR (OR: 36.81; 95% CI: 6.75, 200.61). An apparent super-multiplicative effect of trehalose and glutamate on DR was observed, whereas relative excess risk due to interaction was not significant. The study suggests that trehalose is beneficial to inhibit the occurrence of DR and synergistically decreases the risk of DR with reduced glutamate. Our findings also provide new insights into the mechanisms of DR and further longitudinal studies are required to confirm these findings.
Centre for Biological Timing, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
Search for other papers by Robert Maidstone in
Google Scholar
PubMed
Diabetes, Endocrinology and Metabolism Centre, Manchester University NHS Foundation Trust, NIHR Manchester Biomedical Research Centre, Manchester Academic Health Science Centre, Manchester, UK
Search for other papers by Martin K Rutter in
Google Scholar
PubMed
Oxford Liver Unit, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, UK
Search for other papers by Thomas Marjot in
Google Scholar
PubMed
NIHR Oxford Health Biomedical Research Centre, and NIHR Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK
Search for other papers by David W Ray in
Google Scholar
PubMed
NIHR Oxford Health Biomedical Research Centre, and NIHR Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK
Search for other papers by Matthew Baxter in
Google Scholar
PubMed
Fazel Y Henry L & Wymer M . Global epidemiology of nonalcoholic fatty liver disease—meta-analytic assessment of prevalence, incidence, and outcomes . Hepatology 2016 64 73 – 84 . ( https://doi.org/10.1002/hep.28431 ) 2 European Association
Search for other papers by Wang-shu Liu in
Google Scholar
PubMed
Search for other papers by Ling-yan Hua in
Google Scholar
PubMed
Search for other papers by Su-xiang Zhu in
Google Scholar
PubMed
Search for other papers by Feng Xu in
Google Scholar
PubMed
Search for other papers by Xue-qin Wang in
Google Scholar
PubMed
Search for other papers by Chun-feng Lu in
Google Scholar
PubMed
Search for other papers by Jian-bin Su in
Google Scholar
PubMed
Search for other papers by Feng Qi in
Google Scholar
PubMed
-based HPLC method in a hemoglobin analysis system (D-10, Bio-Rad) was adopted to measure glycosylated hemoglobin (HbA1c) levels. The estimated glomerular filtration rate (eGFR) was calculated based on the Chronic Kidney Disease Epidemiology Collaboration
Search for other papers by Yi Chen in
Google Scholar
PubMed
Search for other papers by Wen Zhang in
Google Scholar
PubMed
Search for other papers by Chi Chen in
Google Scholar
PubMed
Search for other papers by Yuying Wang in
Google Scholar
PubMed
Search for other papers by Ningjian Wang in
Google Scholar
PubMed
Search for other papers by Yingli Lu in
Google Scholar
PubMed
using the following equations according to a previous study ( 18 ): BMI was calculated as weight in kilograms divided by height in meters squared. The eGFR was calculated according to the Chronic Kidney Disease Epidemiology Collaboration equation
Search for other papers by Philippe Jean-Luc Gradidge in
Google Scholar
PubMed
Search for other papers by Nicole G Jaff in
Google Scholar
PubMed
Global Health Research Institute, School of Human Development and Health, University of Southampton, Southampton, UK
Search for other papers by Shane A Norris in
Google Scholar
PubMed
Search for other papers by Marketa Toman in
Google Scholar
PubMed
Search for other papers by Nigel J Crowther in
Google Scholar
PubMed
-induced hypoadiponectinaemia: the opposite influences of central and peripheral fat compartments . International Journal of Epidemiology 2017 46 2044 – 2055 . ( https://doi.org/10.1093/ije/dyx022 ) 12 Turer AT Khera A Ayers CR Turer CB Grundy SM Vega GL Scherer